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Abstract
Background: Although cancer-related fatigue (CRF) has gained increased attention in the past decade, therapy
remains a challenge. Treatment programs are more likely to be effective if the needs and interests of the persons
involved are well represented. This can be achieved by stakeholder engagement.
In this paper, different key stakeholders’ experiences and views on the feasibility of treating CRF in the context of
supportive care in hospital environments are analyzed.
Method: In a qualitative study with the aim of developing an integrative treatment program for CRF, a total of 22
stakeholders (6 medical oncologists, 5 nurses, 9 patients, 1 patient family member, 1 representative of the Swiss
Cancer League) were interviewed either in a face-to-face (n = 12) or focus group setting (n = 2). For data analyses,
the method of qualitative content analysis was used.
Results: The stakeholders referred to different contextual factors when talking about the feasibility of treating CRF
in the context of supportive care in hospital environments. These included: assessment, reporting and information;
treatability; attitude; infrastructure, time-management, costs and affordability; and integrative approach.
Conclusions: Key factors of a feasible treatment approach to CRF are a coherent, cost effective integrative
treatment program facilitated by an interdisciplinary team of health care providers. Furthermore, the treatment
approach should be patient orientated, adopting an individualized approach. The major challenges of making the
integrative treatment program feasible for CRF are resources and interprofessional collaboration.
Keywords: Cancer-related fatigue, Stakeholder engagement, Integrative treatment program, Complementary
medicine, Qualitative study, Feasibility
Background
Cancer-related fatigue (CRF) is a prevalent and complex
syndrome in cancer patients and cancer survivors re-
gardless of tumor and treatment type, and it is still
“underreported, underdiagnosed and undertreated” [1].
A commonly used definition is provided by the National
Comprehensive Cancer Network (NCCN): “CRF is a dis-
tressing, persistent, subjective sense of physical, emo-
tional and/or cognitive tiredness or exhaustion related to
cancer or cancer treatment that is not proportional to
recent activity and interferes with usual functioning” [1].
There is broad agreement that CRF is difficult to treat
with only a single intervention or medication prescribed
alone, because of its multiple possible causative factors
and the variable patterns of clinical expression in
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individual patients [2, 3]. Concerning the decision for
suitable interventions, it is useful to keep in mind that
approximately 51% of cancer patients use complemen-
tary medicine (CM) interventions and wish to include
them in their further therapies [4, 5].
Therefore, a multimodal CRF treatment program com-
bining pharmacological and non-pharmacological con-
ventional and CM interventions seems highly promising.
How patients experience CRF has been adequately ad-
dressed in qualitative health research in the past years
[6]. A review of Scott et al. discusses 154 published pa-
pers of qualitative studies between 1996 and 2009 that
have described the patients’ experiences of CRF and the
consequences for those affected by CRF or involved with
its care. The studies showed relatively homogenous de-
scriptions of the experience of specific sensations, of the
impact of CRF on everyday life and of coping strategies,
all of which were based on the levels of cognition, emo-
tions, and physical expression and impact [6]. There was
much less emphasis on researching the experiences of
other stakeholders involved with CRF, such as caregivers
and health professionals. In addition, participatory ap-
proaches such as stakeholder engagement were rarely
applied to develop and assess treatment programs for
CRF.
We developed an integrative treatment program for
CRF using stakeholder engagement [7]. The treatment
program has three different levels. The first level in-
cludes mandatory nonpharmacological interventions: in-
formation, motivation and exercise. The second level
includes nonpharmacological choice-based interventions,
such as mind-body medicine techniques, acupuncture
and acupressure. The third level includes pharmaco-
logical interventions for severe CRF [7].
The treatment of CRF is first and foremost executed
in the field of supportive cancer care [1]. In addition to
the question of effective treatment options, there are dif-
ferent important contextual factors related to the feasi-
bility of treating CRF, such as human and financial
resources, infrastructure, institutionalization, geograph-
ical reachability, symptom management, prevention and
views on the effectiveness of specific treatments.
In this paper, we present the results from the stake-
holder engagement process asking about the contextual
factors related to the feasibility of treating CRF in the
experiences and views of the stakeholders, i.e., the
people affected by CRF or involved in the treatment of
CRF [8, 9] in supportive care in hospital environments.
This study was conducted concurrently to the treatment
program development study [7].
Methods
In this section, we report the methods applied to answer
the research question about the contextual factors
related to the feasibility of treating CRF. For details
about the approach for developing the integrative treat-
ment program for CRF see Canella et al. 2017 [7].
Stakeholder engagement
Key stakeholders were included to gather data about
their experiences and views on the feasibility of treating
CRF. They represented the following stakeholder groups:
oncologists, radiation oncologists, psycho-oncologists,
nurses, nurse experts (holding a Master’s degree or a
PhD), representatives of a local Swiss Cancer League, pa-
tients, and patient’s family members.
To ensure that we integrated the key stakeholders in
the study and that we obtained the relevant experiences
with CRF as well as views on CRF [7], we recruited ac-
cording to the principles of “theoretical sampling” [10].
This meant also to recruit participants from within and
from outside the University Hospital Zurich.
From the group of the involved stakeholders, we
formed a stakeholder advisory board. We aimed at in-
volving one board member of every stakeholder group.
We directly approached persons of whom we knew were
very experienced with CRF to join the advisory board.
We asked the different clinic directors of our oncology
department as well as the nurse director and the repre-
sentative of a local Swiss Cancer League. In addition, we
asked one of our CRF patients to be part of the board.
Due to availability issues, the patient family member un-
fortunately was not able to participate in the advisory
board.
The seven board members all had experience with
CRF and participated in the whole research process,
which included face-to-face interviews, an advisory
board meeting about the interpretation of the results
and the further development of the integrative treatment
program, and several written feedback rounds to reach
consensus about the final treatment program.
Qualitative data collection and analysis
The qualitative, participatory study was ethnographic in
its nature [11–14]. Data collection and analysis followed
the principles and methods of qualitative content ana-
lysis [11]. Qualitative content analysis involves identify-
ing key topics, ideas and their relationships. In addition,
formal characteristics of the data and their context are
analyzed [11–14]. We applied qualitative content ana-
lysis to focus on the whole spectrum of topics and view-
points that the stakeholders brought up regarding their
experiences with CRF and the feasibility of treating it.
The stakeholders were interviewed either in a semi-
structured face-to-face interview or in a focus group set-
ting, both of approximately 90 min in duration [13–15].
They could choose to be interviewed at our institute, at
their workplace or at their home. The interviewees were
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asked open questions about their experiences and needs
concerning CRF and their opinions of the feasibility of
treating CRF.
All interviews were audio recorded, transcribed verba-
tim and analyzed using qualitative data analysis software
MAXQDA, version 11.1.2. We performed investigator
triangulation to enhance the reliability of the analysis
and the results [16]. In an iterative research process, two
researchers analyzed the interview data independently
and then discussed and revised their findings until a
consensus was reached. The analyses consisted of an
audio-club [17] where the researchers listened to the ori-
ginal audio-data in real time and then discussed their
perceptions and interpretations with each other. Subse-
quently, a thematic coding in units of meaning was exe-
cuted [10, 18] to identify and describe the topics,
contextual factors and stakeholder experiences with CRF
and its treatment [7].
Results
Participants
Overall, 22 stakeholders were interviewed (see Table 1).
With the health care providers, we conducted nine
face-to-face interviews and one focus group consisting of
one nurse and two nurse experts. On average, the health
care providers estimated that approximately 57% (range
10% 100%) of their cancer patients experience CRF.
With the patients, we conducted two face-to-face in-
terviews and one focus group with seven participants.
The patients experienced different types of cancer and
were in different stages of treatment after their diagno-
sis. They all combined standard cancer therapy and CM
treatments. Between the patients’ cancer diagnoses and
their CRF diagnoses, the average timespan was 10
months. In addition, a numeric rating scale with two
questions was used to confirm the CRF diagnosis of the
participating patients at the beginning of the project [7,
19]. For further details about the patients cancer charac-
teristics see Canella et al. [7].
The stakeholder advisory board was formed out of the
22 stakeholders. The seven individual board members
were interviewed face-to-face as stakeholders independ-
ent of the advisory board meetings [7].
Contextual factors related to the feasibility of treating
CRF in supportive care in hospital environments
The stakeholders referred to different main topics when
talking about the feasibility of treating CRF: assessment,
reporting and information; treatability; attitude; infra-
structure, time-management, costs and affordability; and
integrative approach.
Selected original quotes representative of the ad-
dressed topics and views during the interviews are pre-
sented in Table 2. In addition, all the terms in quotation
marks indicate original quotes from the stakeholders.
Assessment, reporting and information
The medical doctors, nurses and nurse experts stressed
the challenge of assessing CRF and asking their patients
about CRF-related symptoms periodically. The health
care providers usually did not use a standard diagnostic
tool for assessing CRF. “Everyone had more or less an
individual approach” (medical oncologist) to ask their
patients about symptoms of CRF. It was a challenge for
the health care providers to keep track of CRF in their
patients because CRF can have multiple causes, can ap-
pear in very different stages of cancer and can differ in
its clinical expression in the individual patients. The
psycho-oncologist added that it is often difficult to dif-
ferentiate between CRF and other psychological condi-
tions, such as depression or anxiety. A nurse expert
linked the topic of assessment and reporting with the
observation that medical doctors are often too overbur-
dened with the standard cancer therapy consultation to
execute a systematic CRF assessment. She suggested that
a systematic implementation of a standard diagnostic
tool for CRF might be more feasible if an advanced
Table 1 Stakeholder characteristics
Stakeholder groups Total (n = 22) Gender N Mean Age (Range)
Patients 9 Female 7 55 (35–65)
Male 2
Patient’s family member 1 Male 1 33
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Table 2 Selected stakeholders’ original quotes representative of the addressed topics and views during the interviews
Stakeholders original quotes
Assessment and Reporting Radiation oncologist: “From my view, we do not ask/ nor use a systematic assessment [of CRF] at the
moment, no quantification”.
Oncologist: “Everyone has their own technique what is been asked and how you ask. And then, it is difficult
asking things only to record it but not having a solution for it”.
Psycho-oncologist: “The problem with CRF is that it does not appear at a certain point in time … it can
happen at any point during the course [of cancer disease]. And we do not know 100%, as far as I know,
what the causes are … and which factors play a role in it.”
Psycho-oncologist: “The big challenge is to distinguish [CRF] from other psychiatric diseases, above all from
depression, but also from anxiety. That is a big diagnostic and therapeutic challenge”.
Nurse expert: “You could delegate it to the nurses because the medical doctors always have so little time. I
mean the assessment [of CRF] … if you had an algorithm of what data, clinical parameters and so on to
gather … that could be an interesting job for an advanced nursing practitioner”.
Radiation-oncologist: “That [addressing fatigue symptoms] is not in the foreground in the patients. Surviving
is in the foreground in the patients who are really in the middle of a cancer therapy. Then, the severe side
effects, acute side effects that come from radiation. So, fatigue does not occupy a big space neither in the
informative consultation nor in the consciousness of the patient”.
Treatability Oncologist: “It is a bit frustrating. You try to help, trying to improve some things, but mostly, time must just
pass by and it gets a little better in the end. We don’t have good therapy options available.”
Radiation-oncologist: “We do not really have a specific systematic therapy of CRF within our clinic treatment
guidelines … .nor do we have a specific offer [for the patients].”
Nurse expert: “Concerning therapy strategies, I see a bit a split up between physical, emotional, mental and I
would also add spiritual and of course complementary methods … ”
Nurse expert: “People are telling me that they cannot trust their own body anymore because they suffer
from cancer and did not notice it. Afterwards, the fatigue and exhaustion kick in because of the therapy.
And then there are the surgeries, being disfigured, not being able to find yourself beautiful anymore.
Feeling a distance to their own body, looking from the outside to the own body and saying, this is
someone else. I don’t want anything to do with this …. And then you should return to life and it does not
work … You cannot get out of your own way forever … if you want to go for a swim or the hair is grey all
of a sudden. It is really important that the people get back these abilities, that they are able to influence
their acts and experiences … ”
Patient family member: “… it is searching for a dialogue and rediscovering the awareness of the own body
… sensing yourself … and trying to create a sense of achievement together … ”
Patient: “How do you fight fatigue?...If you are in it, you cannot make it. The exhaustion makes it impossible
to move … and then, there is the pain … finally, you resign, and then the spiral spins down fast … when I
am inside the fatigue or in this vicious circle, I do not think that I am capable of anything … It would be
important to begin early in the therapy with physiotherapy to avoid physical imbalances and physical
decline … ”
Attitude Patient family member: “Something that you can do by yourself. Nothing that is additionally inflicted upon
you or is being done to you from the outside … Something that I can contribute to the whole. I believe
that this should lead to a certain kind of self-confidence, that you are able to do something and that you
can do something good to yourself in this time.”
Oncologist: “Empowerment. Keep them in the driver seat.”
Nurse expert: “Individualizing and prioritizing … for [treating] very exhausted people … when you do
individualize, you automatically determine priorities … ”
Patient: “After the disease, I would have wished that the hospital told me what I can do against the fatigue
… I googled a bit, but in this situation, you are still so tired and everything needs so much energy. Life
alone costs so much energy … you are more reserved, and you are not in the mood to try things. I would
have wished to receive some addresses or similar things … something where I would have been
accompanied … how do I cope with … the whole fatigue … and what can I do against it?...You are so
tired and without energy that you are happy when others decide for you … because it has to do with
effort … I would have wished different options and offers open to choose from what I wanted … ”
Patient: “After the active cancer treatment … you are discharged, then you have to fend for yourself … you
are pretty much left alone”.
Oncologist: “Certain cancer patients that have never learned to care for themselves … you cannot expect
them to jump on and say: Yay, now I do something for myself! … They don’t turn around 180 degrees and
act completely different than their 50, 60 years before … ”
Infrastructure, time-management, costs
and affordability
Oncologist: “If we want it to be done [establishing a CRF treatment program], we need a point of care. That
means, on the one hand, the medical doctor and, on the other hand, the nurses who are near the patients
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nursing practitioner could take over that task from the
medical doctors.
Some health care providers reported that their patients
rarely addressed problems or symptoms of fatigue dur-
ing the consultation because they were focused on sur-
viving and on the more acute side effects of active
cancer therapies.
Patients felt that they were not informed specifically
enough about how to treat CRF. They felt like they had
to search for treatment options on their own what was
challenging while experiencing simultaneously CRF.
They wished they could have been monitored for CRF
throughout the active cancer therapy but especially after
active treatment. The advisory board discussed when
Table 2 Selected stakeholders’ original quotes representative of the addressed topics and views during the interviews (Continued)
Stakeholders original quotes
… It means you need rooms within the clinic, as near as possible, as visible as possible … in an ideal
situation … We are way too disparate … people are too far away … The patients have to gather together
different offers. That is not always easy. It is like in the supermarket where they put the chocolate things
before the cash desk. You consume of what you know to exist. You seduce by being there.”
Oncologist: “The information has to be done by the point of care … I say by the nurses first … because
they have a longer exposure to the patients … there are other points of contacts where topics can be
addressed that usually fall short...The information also has to be there, ideally at a desk where you can get
the information or patients can ask about while they are waiting … or while passing by when leaving [the
hospital] … If I could build a hospital, I would want a shopping center … with psycho-oncology, social ser-
vices … cancer league … a welcome desk with brochures and information material, a wigmaker … and so
on and so on … ”
Nurse expert: “They [cancer patients] often have some physiotherapy … or a psycho-oncological consult-
ation or a follow up or the baby-sitting that didn’t work and then another appointment follows and another
and another and another. Or they have long ways … It is not to be underestimated, because the survivors
are tired. And they have cognitive dysfunctions and they are exhausted afterwards and know, when the
concentration [of an appointment or intervention] is behind them, they have consumed up all their energy
for the whole day”.
Radiation-oncologist: “After the motto, more is better, I do not believe in this. I do not consider it as useful
applying five different methods to attack CRF...One method for sure. Two, ok. I would not expect the
patients to do more.”
Patient: “Maybe the psycho-education would have been feasible if you say, ok, today after or before the
chemo you have another hour. How much outcome you would have in doing it that way, I don’t know.
How receptive you would be, also cognitively. This is another thing that you are not receptive at all. Maybe
it [the treatment program] is feasible if it is integrated into the proceedings of the hospital … ”
Nurse expert: “Maybe we could create an offer for people who do not live on the sunny side of life. Some
foundation or donation accounts … to support something.” … “I would connect it to the indication...In case
of this diagnoses maybe one part would be funded. That would be useful … and then probably more
evidence is needed.”
Oncologist: “There is this consumerism. I think, it would be good if the people must pay a bit more because
that causes another identification.”
Integrative approach Nurse expert: “They [the patients] really came and asked, what can we do? Additionally, complementary?
What offers are there? What would help me?”
Psycho-oncologist: “Personally, I really like complementary medicine, because it … offers something for the
patients that helps them. Personally, I prefer that patients who suffer from psychological problems, who are
stressed, that they learn something active, how they can create their life themselves again … And patients
love complementary medicine anyway because they feel that it is something good for them and that it
helps them and does not harm.”
Nurse-expert: “We have some [nurses] who are good in the complementary medicine approaches, who are
vocationally educated in it. We also refer [patients] to your clinic [Institute for complementary and
integrative medicine]. We often do this. I think it is strongly growing … there is a tendency. Now, it is more
in the heads of the medical doctors and the nurses.”
Patient: “We, the patients, have to initiate and build it. There is no net of connections or networking among
the medical doctors yet. And this is something where both sides could benefit from one another, and in
the end, the patient has a huge benefit from it. I really cannot understand why they don’t do it.”
Nurse expert: “What I think is that it is mostly a single element [from a complementary medicine approach].
Therefore, it is not a package where you could choose something and that is harmonized to one another. It
is rather that the patients try something because he has heard of it or someone recommended it. He just
tries and either it is good or not. It is complex. I think, most [patients] try something.”
Nurse expert: “We consider ourselves as scientists, natural scientists … I tell [my patients] that my belief
system differs from these [complementary medicine approaches], but that I am – of course – full of respect
and acceptance for these methods as long they don’t harm themselves.”
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would be a good point in time to inform the patients
about CRF. They agreed that cancer patients should be
informed early after their diagnoses and reflected on the
possibility of creating an online information tool for the
patients.
Treatability
The health care providers often did not see good results
when trying to treat CRF. They also mentioned that
there was no specific treatment for CRF in their hospital
at the time of the interview. It was a problem for the
health care providers that CRF could not be treated with
a single, simple and effective intervention, so they opted
for interdisciplinary collaboration and an integrative
treatment program when approaching the treatment of
CRF. A nurse expert expressed the need for approaches
at different levels, including the physical, emotional,
mental and spiritual levels.
Many stakeholders also reflected on the goal of CRF
treatment, which they saw as increasing the energy level
of the patients, improving their quality of life and help-
ing them adopt coping strategies. A nurse expert differ-
entiated between patients in curative and palliative
situations. To her, the goal in palliative patients should
be “coping” (nurse expert) and “managing their own en-
ergy levels” (nurse expert) throughout the day, whereas
in a curative setting, the patients should aim to regain
their energy mainly by exercising. Most stakeholders
stressed that one of the most important goals is to pro-
vide patients with options that help them regain trust in
their own bodies and in their abilities, as many cancer
patients lose faith in their own bodies. For the stake-
holders, this was also strongly linked with the topic of
regaining self-efficacy. The stakeholders thought that
this could be best achieved by exercising and by psy-
choeducation. However, it is a major challenge for
people with CRF to become active on a regular basis be-
cause being active and experiencing CRF are contradict-
ory in their nature. The stakeholders differed in their
views on how to approach this challenge. Whereas some
patients would have preferred personal coaching with an
individual workout program, a few health care providers
opted for group trainings tailored for CRF patients, with
the focus not only on the financial and infrastructural
feasibility but also on the possible benefits of the group
setting, such as sharing similar diagnoses, exchanging
experiences and motivating each other.
Attitude
The stakeholders agreed on the attitudes of the patients
and health care providers needed for a successful inte-
grative CRF treatment program. The treatment approach
should be patient-oriented, should focus on self-care op-
tions and should create possibilities for self-management
for the patients. According to the stakeholders, a
patient-oriented approach is also needed to strengthen
patients’ self-efficacy and to overcome feelings of help-
lessness that often go along with experiencing a life-
threatening disease such as cancer.
The nurses and nurse experts stressed that an individ-
ualized approach is needed. This would consider pa-
tients’ cultural and social backgrounds as well as their
individual experiences with their cancer and with CRF,
recognizing the importance of connecting with the pa-
tients’ resources and interests.
The patients unanimously agreed with the patient
orientation, but also wished to be simultaneously in-
formed, monitored and accompanied by health care pro-
viders because they felt unable to act completely
autonomously while experiencing deep exhaustion and
fatigue. They often felt they were being left alone with
their CRF, especially after active cancer treatment.
Some health care providers pointed out that an inte-
grative approach and a focus on self-care often require a
change in health behavior in the patient and that this is
a serious challenge while experiencing cancer and CRF.
Infrastructure, time-management, costs and affordability
The health care providers identified a need for a multi-
modal approach to treat CRF and talked about the con-
sequences that come along with such an approach. First,
hospitals are always short of manpower, infrastructure
and time to meet all the different needs of individual pa-
tients. In addition, it is a challenge to coordinate the
treatment between different departments and ensure the
flow of information between all involved parties. Some
stakeholders imagined a “shopping-center” (medical on-
cologist) or “drop-in-center” (medical oncologist) where
the different treatments would be coordinated, moni-
tored and located in the same building.
Normally, cancer patients have many appointments
that can result in an overload of consultations and ther-
apies. Consequently, most stakeholders opted for a
prioritization of treatments – also based on the severity
of CRF in the individual patient – and a focus on op-
tions that could be executed at home, such as exercising
or acupressure. According to the stakeholders, prioritiz-
ing is even more important for CRF patients because
they experienced these patients to be very restricted on
all levels. Too many appointments limit the processing
of information and interventions in CRF patients. There-
fore, a good organization of the appointments is needed
as well as locating therapies within a comfortable geo-
graphical distance from where the patients live. In
addition, some stakeholders pointed to the challenge of
coordinating work with an extensive treatment program,
as is often the case in cancer patients.
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The stakeholders agreed that the integrative treatment
program would be most feasible if it would be fully cov-
ered by public health insurance. Admission into public
health insurance usually requires standard diagnostic
tools and evidence from good quality randomized con-
trolled clinical trials for the interventions; both would be
currently available. However, there were also some opin-
ions from health care providers that patients should pay
privately to increase their adherence to the treatment
program. Simultaneously, they opted for establishing a
“social welfare fund for cases of hardship” (medical on-
cologist). The nurse experts pointed out that cancer sur-
vivors usually struggle financially because they have lost
their jobs or cannot work anymore because of their
cancer.
Integrative approach
All patients wished to have an integrative approach to
their therapies. They asked their medical doctors or
nurses about what complementary medicine (CM) inter-
ventions they could add to their therapy.
In general, the health care providers considered CM
approaches as especially supportive for their patients,
contributing actively to their recoveries. They noticed a
growing awareness in medical doctors and hospital envi-
ronments of the possibility of adopting an integrative ap-
proach and referring patients to the respective
institutions. However, patients complained about a lack
of interdisciplinary collaboration between the different
health care providers.
The health care providers did not have the impression
that their patients followed a coordinated integrative
treatment program at the time of the interviews. Instead,
they experienced isolated applications of single CM in-
terventions in their patients, such as yoga, diets or phy-
tomedicine, which had been recommended to the
patients by their private environments or were found on
the internet.
The health care providers themselves only recom-
mended CM interventions for which they personally had
a clear idea of the benefits. Some of them adopted a
stance of not believing in certain interventions but
thinking “even if it is not effective, it does not harm”
(nurse expert). Some health care providers were critical
about the effectiveness of CM interventions and opted
for strict “academic, scientific, evidence-based comple-
mentary medicine” (radiation-oncologist).
First experiences with the implementation of the inte-
grative CRF treatment program in our clinic point to the
program being feasible if patients come into the clinic
with CRF as their main complaint. However, more often,
CRF is one of many complaints that cancer patients re-
port when coming to our clinic. Our medical doctors
then prioritize the interventions with the patients.
Exercising and mind-body medicine techniques are dis-
cussed with every CRF patient. Then, usually one other
intervention from the program for CRF is selected, often
acupuncture or acupressure. In addition, procedures or
remedies which cover both CRF and the patients’ other
symptoms are selected, such as mistletoe extract or
other herbal drugs.
Discussion
Table 3 provides a summary of barriers and facilitators
regarding the feasibility of treating CRF in supportive
care in hospital environments in the views of the
stakeholders.
Although all the discussed topics are linked to differ-
ent challenges of making the suggested integrative treat-
ment program feasible for CRF, we identified two major
challenges out of the interviews with the stakeholders:
first, staff and financial resources, and second, the coord-
ination of such a multimodal, interprofessional approach
in terms of infrastructure, flow of information and man-
ageable organization. To date, supportive cancer therap-
ies are still heavily competing with antineoplastic
therapies for limited health care funding [20]. As the fi-
nancial burden of cancer care increases in the future
[21–23], health care funding remains a major challenge
for supportive cancer therapies. Increasing reimburse-
ment for supportive therapies would require a consider-
able shift in the rating of the importance of supportive
care compared to antineoplastic therapies by govern-
ments, health care policy makers and investors [20, 24].
However, as cancer survivors are a rapidly growing
population, awareness of the need for supportive cancer
therapies increases simultaneously. Not only the finan-
cial burden of cancer disease in patients has to be con-
sidered, but also the cognitive, physical, emotional and
spiritual burdens and their impacts on productivity, citi-
zenship and contribution to society [20, 25]. Apparently,
there is no global solution either for solving infrastruc-
tural problems or for the coordination of a multimodal
treatment approach and interprofessional collaboration.
There is a broad consensus that interprofessional collab-
oration in supportive cancer care ideally must entail a
united team effort of “medical, nursing, psycho-social
and spiritual support into a global and anticipated team
approach to the patients and their social environment”
([26], p.10). However, practical solutions must be found
and implemented locally, ensuring the transfer of know-
ledge and professional expertise [25, 27]. To overcome
the gap between research and implementation into prac-
tice, key stakeholders – including scientists, health care
policy makers, funders, health professionals, advocacy
groups, patients and caregivers – have to collaborate on
the basis of “trust, mutual respect and shared responsi-
bility” ([25] , p.580).
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Potential approaches
In our clinic, we address these challenges in various
ways. As we are part of the University Hospital Zurich
all our supportive cancer care interventions are covered
by the public health insurance. This enables almost all
patients to have access to our treatment options. We
handle the challenge of the coordination of such a multi-
modal, interprofessional approach in different ways. We
built an interdisciplinary team of medical doctors with
different integrative medicine expertise, psychothera-
pists, nurses and a nutritionist in our clinic. The whole
clinical team regularly meets for case conferences where
the treatment of single patients is discussed and
coordinated.
A promising attempt to approach the challenge of a
globally standardized treatment of CRF is the implemen-
tation of evidence-based guidelines for CRF manage-
ment, such as the NCCN guideline [1] or the CAPO
guideline [28]. Assessments of the guidelines showed
that they face similar problems concerning their feasibil-
ity: availability of the guidelines and diagnostic tools,
education of health professionals and patients,
coordination of an interprofessional team, integration
with existing practices and patient-orientation (e.g. [29]).
Strengths and limitations
The study has strengths and limitations. We gathered
the experiences and views of CRF patients and included
other key stakeholders, such as health care providers or
patient family members, to obtain a broader perspective
towards an integrative treatment approach to CRF, espe-
cially considering the contextual factors that influence
the feasibility of treating CRF. In addition, we adopted a
participatory approach by working with a stakeholder
advisory board. A limitation of the study is that not all
stakeholders were equally included, and some were even
missing completely, such as allied health practitioners,
hospital administrators or health insurance representa-
tives. Other stakeholders might have provided a broader
perspective. Another limitation is that we conducted the
study in a hospital environment that might not be ap-
plicable to other health care environments.
Future research should include the scientific evalu-
ation of the integrative treatment program for CRF,
Table 3 Summary of barriers and facilitators regarding the feasibility of treating CRF in supportive care in hospital environments in
the views of the stakeholders
Barriers Facilitators
Assessment ⋅ No standard diagnostic tool ⋅ Standard diagnostic tool
⋅ No systematic CRF assessment ⋅ Systematic CRF assessment
⋅ Patient orientation
Reporting ⋅ CRF has multiple causes ⋅ Encouraging patients to report CRF symptoms
⋅ CRF differs in its clinical expression in the individual patients
⋅ Patients rarely address symptoms of fatigue on their own accord
Information ⋅ No specific systematic information of patients about CRF ⋅ Information about CRF early after diagnoses
⋅ Online information tool
Treatability ⋅ Not treatable with a single intervention ⋅ Interdisciplinary collaboration
⋅ No treatment guidelines in the hospital ⋅ Integrative treatment program
⋅ Monitoring
⋅ Working towards self-efficacy of the patients
Attitude ⋅ Feelings of helplessness ⋅ Patient-orientation
⋅ Experiencing a life-threatening disease ⋅ Individualized approach
⋅ Self-Care options
⋅ Self-management
Infrastructure ⋅ Hospitals are short of infrastructure ⋅ Drop-in-center (coordination, monitoring)
Time-management ⋅ Doctors and patients are short of time ⋅ Prioritization of treatments
⋅ Overload of consultations and therapies ⋅ Focus on self-care
⋅ Coordination of work and treatment ⋅ Geographically reachable treatment options
Costs and affordability ⋅ Hospitals are short of manpower ⋅ Coverage by public health insurance
⋅ No coverage by public health insurance ⋅ Social welfare funds
Integrative approach ⋅ Lack of interdisciplinary collaboration ⋅ Evidence-based integrative medicine approach
⋅ Lack of coordinated integrative programs ⋅ Integrative treatment program
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addressing especially the relevant contextual factors, in-
frastructure, resources, cost-effectiveness and interpro-
fessional collaboration.
Conclusion
Key factors of a feasible treatment approach to CRF are
a coherent, cost effective integrative treatment program
facilitated by an interdisciplinary team of health care
providers. Ideally, such a program should entail a coor-
dinated monitoring of the treatment of the patients. Fur-
thermore, the treatment approach should be patient
orientated. Adopting an individualized approach, health
care providers should aim at self-efficacy of the patients.
Despite the numerous barriers, a clinic of integrative
medicine embedded in a hospital environment and with
a focus on supportive cancer care has the potential of
realizing such a feasible integrative treatment program
for CRF.
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